Warning: The NCBI web site requires JavaScript to function. more...
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance.
Alexander N, Sutherland C, Roper C, Cissé B, Schellenberg D.
Malar J. 2007 Jan 22;6:9.
Related citations
Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.
O'Meara WP, Smith DL, McKenzie FE.
PLoS Med. 2006 May;3(5):e141. Epub 2006 Apr 4.
The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi).
O'Meara WP, Breman JG, McKenzie FE.
Malar J. 2005 Jul 20;4:33. Review.
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.
White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP.
Malar J. 2009 Nov 11;8:253.
Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants.
Ross A, Penny M, Maire N, Studer A, Carneiro I, Schellenberg D, Greenwood B, Tanner M, Smith T.
PLoS One. 2008 Jul 16;3(7):e2661. Erratum in: PLoS ONE. 2009;4(3). doi: 10.1371/annotation/5dba0336-1efe-4387-8d9f-946b231331f3.
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
Souares A, Lalou R, Sene I, Sow D, Le Hesran JY.
Malar J. 2009 Jun 4;8:118.
Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
ter Kuile FO, van Eijk AM, Filler SJ.
JAMA. 2007 Jun 20;297(23):2603-16. Review.
Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern Tanzania.
Armstrong Schellenberg JR, Shirima K, Maokola W, Manzi F, Mrisho M, Mushi A, Mshinda H, Alonso P, Tanner M, Schellenberg DM.
Am J Trop Med Hyg. 2010 May;82(5):772-81.
Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, Puyol L, Berzosa P, Dobaño C, Aide P, Sacarlal J, Benito A, Alonso P, Menéndez C.
J Infect Dis. 2008 Jun 15;197(12):1737-42.
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.
Malar J. 2008 Nov 2;7:229.
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
Clarke SE, Jukes MC, Njagi JK, Khasakhala L, Cundill B, Otido J, Crudder C, Estambale BB, Brooker S.
Lancet. 2008 Jul 12;372(9633):127-38. Erratum in: Lancet. 2009 Jan 3;373(9657):30.
Review: Intermittent preventive treatment--a new approach to the prevention of malaria in children in areas with seasonal malaria transmission.
Greenwood B.
Trop Med Int Health. 2006 Jul;11(7):983-91. Review.
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana.
Cairns M, Carneiro I, Milligan P, Owusu-Agyei S, Awine T, Gosling R, Greenwood B, Chandramohan D.
PLoS One. 2008 May 21;3(5):e2227.
Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda.
Mbonye AK, Bygbjerg I, Magnussen P.
Int J Infect Dis. 2008 Jan;12(1):22-9. Epub 2007 May 29.
The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.
Pool R, Mushi A, Schellenberg JA, Mrisho M, Alonso P, Montgomery C, Tanner M, Mshinda H, Schellenberg D.
Malar J. 2008 Oct 21;7:213.
Assessing the impact of educational intervention for improving management of malaria and other childhood illnesses in Kibaha District-Tanzania.
Nsimba SE.
East Afr J Public Health. 2007 Apr;4(1):5-11.
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.
Malar J. 2009 Jan 5;8:2.
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.
Smith DL, Klein EY, McKenzie FE, Laxminarayan R.
Malar J. 2010 Jul 23;9:217.
Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).
Kobbe R, Adjei S, Kreuzberg C, Kreuels B, Thompson B, Thompson PA, Marks F, Busch W, Tosun M, Schreiber N, Opoku E, Adjei O, Meyer CG, May J.
Malar J. 2007 Dec 9;6:163.
Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (west Africa).
Ntab B, Cissé B, Boulanger D, Sokhna C, Targett G, Lines J, Alexander N, Trape JF, Simondon F, Greenwood BM, Simondon KB.
Am J Trop Med Hyg. 2007 Sep;77(3):411-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on